Compare OPAL & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAL | INCR |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.3M | 79.3M |
| IPO Year | N/A | N/A |
| Metric | OPAL | INCR |
|---|---|---|
| Price | $2.18 | $0.91 |
| Analyst Decision | Sell | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.81 | N/A |
| AVG Volume (30 Days) | ★ 386.4K | 190.7K |
| Earning Date | 11-06-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $329,243,000.00 | $72,158,312.00 |
| Revenue This Year | $17.15 | $69.54 |
| Revenue Next Year | $22.04 | $41.75 |
| P/E Ratio | $95.04 | ★ N/A |
| Revenue Growth | ★ 7.26 | N/A |
| 52 Week Low | $1.26 | $0.68 |
| 52 Week High | $4.08 | $1.78 |
| Indicator | OPAL | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 31.20 |
| Support Level | $2.12 | $0.87 |
| Resistance Level | $2.87 | $1.08 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 27.01 | 33.23 |
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.